Azatadine Maleate

马来酸阿扎他定

Report date: 2022/01/14 13:23:58
NME

Base Information

Drug NameAzatadine Maleate
Drug Alias NameAzatadinum马来酸哌吡庚啶马来酸阿扎他啶azatadinaOptimine +[6
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionHistamine receptor antagonists
TargetsHistamine receptor
Therapy Area/IndicationsRhinitis, Allergic
Global Approved IndicationsRhinitis, Allergic
Approved Indications in ChinaN/A
Original Approved Country/TerritoryUnited States
Original Approved Date1977/03/29
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusWithdrawn
Highest Status in ChinaN/A
Originator CompaniesMerck & Co Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesSchering Ag
Active IndicationsN/A
Inactive IndicationsRhinitis, Allergic

Other Information

ATC CodeR06AX09